Literature DB >> 22336748

Effectiveness of group and self-help cognitive behavior therapy in reducing problematic menopausal hot flushes and night sweats (MENOS 2): a randomized controlled trial.

Beverley Ayers1, Melanie Smith, Jennifer Hellier, Eleanor Mann, Myra S Hunter.   

Abstract

OBJECTIVE: The aim of this study was to examine the effectiveness of group cognitive behavioral therapy (CBT) and guided self-help CBT in reducing hot flush and night sweat (HF/NS) problem rating at 6 and 26 weeks after randomization.
METHODS: This was a randomized control trial of 140 women having 10 or more problematic HF/NS a week for at least a month. The primary outcome was HF/NS problem rating (1-10) at 6 weeks after randomization. Secondary outcomes were physiologically measured HF/NS at 6 weeks; HF/NS problem rating at 6 weeks; and frequency, mood (Women's Health Questionnaire), and health-related quality of life (General Health Survey Short Form-36) at 6 and 26 weeks. Intention-to-treat analysis was used, and between-group differences were estimated using linear mixed models.
RESULTS: Baseline mean (SD) HF/NS weekly frequency was 63.15 (49.24), and problem rating was 5.87 (2.28). Group and self-help CBT both significantly reduced HF/NS problem rating at 6 weeks-group CBT versus no treatment control (NTC; adjusted mean difference, 2.12; 95% CI, 1.36-2.88; P < 0.001) and self-help CBT versus NTC (adjusted mean difference, 2.08; 95% CI, 1.29-2.86; P < 0.001)-and at 26 weeks-group CBT versus NTC (adjusted mean difference, 1.33; 95% CI, 0.54-2.13; P = 0.001) and self-help CBT versus NTC (adjusted mean difference, 1.19; 95% CI, 0.36-2.02; P = 0.005). Group and self-help CBT significantly reduced night sweat frequency at 6 and 26 weeks. There were improvements in mood and quality of life at 6 weeks and improved emotional and physical functioning for group CBT at 26 weeks.
CONCLUSIONS: These results suggest that CBT delivered in group or self-help format is an effective treatment option for women during the menopause transition and postmenopause with problematic HF/NS.

Entities:  

Mesh:

Year:  2012        PMID: 22336748     DOI: 10.1097/gme.0b013e31823fe835

Source DB:  PubMed          Journal:  Menopause        ISSN: 1072-3714            Impact factor:   2.953


  27 in total

1.  Efficacy of a biobehavioral intervention for hot flashes: a randomized controlled pilot study.

Authors:  Debra L Barton; Kelliann C Fee Schroeder; Tanima Banerjee; Sherry Wolf; Timothy Z Keith; Gary Elkins
Journal:  Menopause       Date:  2017-07       Impact factor: 2.953

2.  Management of Potential Long-Term Toxicities in Breast Cancer Patients.

Authors:  C C O'Sullivan; K J Ruddy
Journal:  Curr Breast Cancer Rep       Date:  2016-10-13

3.  Hot flashes: the ongoing search for effective interventions.

Authors:  Kunal C Kadakia; Charles L Loprinzi; Debra L Barton
Journal:  Menopause       Date:  2012-07       Impact factor: 2.953

4.  Survivorship, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.

Authors:  Crystal S Denlinger; Tara Sanft; K Scott Baker; Shrujal Baxi; Gregory Broderick; Wendy Demark-Wahnefried; Debra L Friedman; Mindy Goldman; Melissa Hudson; Nazanin Khakpour; Allison King; Divya Koura; Elizabeth Kvale; Robin M Lally; Terry S Langbaum; Michelle Melisko; Jose G Montoya; Kathi Mooney; Javid J Moslehi; Tracey O'Connor; Linda Overholser; Electra D Paskett; Jeffrey Peppercorn; M Alma Rodriguez; Kathryn J Ruddy; Paula Silverman; Sophia Smith; Karen L Syrjala; Amye Tevaarwerk; Susan G Urba; Mark T Wakabayashi; Phyllis Zee; Deborah A Freedman-Cass; Nicole R McMillian
Journal:  J Natl Compr Canc Netw       Date:  2017-09       Impact factor: 11.908

5.  Midlife women's symptom cluster heuristics: evaluation of an iPad application for data collection.

Authors:  Nancy Fugate Woods; Rita Ismail; Lauri A Linder; Catherine Fiona Macpherson
Journal:  Menopause       Date:  2015-10       Impact factor: 2.953

Review 6.  Risk factors, pathophysiology, and treatment of hot flashes in cancer.

Authors:  William I Fisher; Aimee K Johnson; Gary R Elkins; Julie L Otte; Debra S Burns; Menggang Yu; Janet S Carpenter
Journal:  CA Cancer J Clin       Date:  2013-01-25       Impact factor: 508.702

Review 7.  Contemporary Non-hormonal Therapies for the Management of Vasomotor Symptoms Associated with Menopause: A Literature Review.

Authors:  Sabrina Sahni; Angie Lobo-Romero; Taryn Smith
Journal:  touchREV Endocrinol       Date:  2021-10-13

8.  A randomised controlled trial of a cognitive behavioural intervention for men who have hot flushes following prostate cancer treatment (MANCAN): trial protocol.

Authors:  Omar Yousaf; Evgenia Stefanopoulou; Elizabeth A Grunfeld; Myra S Hunter
Journal:  BMC Cancer       Date:  2012-06-11       Impact factor: 4.430

Review 9.  The Effects of Estrogens on Neural Circuits That Control Temperature.

Authors:  Zhi Zhang; Johnathon R DiVittorio; Alexia M Joseph; Stephanie M Correa
Journal:  Endocrinology       Date:  2021-08-01       Impact factor: 4.736

10.  Telephone-Based Cognitive Behavioral Therapy for Insomnia in Perimenopausal and Postmenopausal Women With Vasomotor Symptoms: A MsFLASH Randomized Clinical Trial.

Authors:  Susan M McCurry; Katherine A Guthrie; Charles M Morin; Nancy F Woods; Carol A Landis; Kristine E Ensrud; Joseph C Larson; Hadine Joffe; Lee S Cohen; Julie R Hunt; Katherine M Newton; Julie L Otte; Susan D Reed; Barbara Sternfeld; Lesley F Tinker; Andrea Z LaCroix
Journal:  JAMA Intern Med       Date:  2016-07-01       Impact factor: 44.409

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.